Skip to main content

Table 1 Baseline characteristics of general practitioners (GPs) from all participating countries (N countries = 31, N GPs = 1,706)

From: General practitioners’ deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries

  GPs’ deprescribing decisionsa
(N = 1,428, only complete records)
  
GP characteristics Overall Deprescribing in < 6 case vignettes
(n = 370)
Deprescribing in all 6 case vignettesb
(n = 1,058)
Crude odds ratio of deprescribing in all 6 case vignettesc
(95% CI)
P-valued
Sex
 female, n (%) 1,021 (60) 240 (65) 593 (56) 0.74 (0.57 to 0.96) 0.024
 male, n (%) 685 (40) 130 (35) 465 (44) ref.  
Age, in years
mean (standard deviation) 50 (12) 49 (12) 50 (12) per 10 years:
1.14 (1.02 to 1.28)
0.020
Clinical experience as GP, in years
mean (standard deviation) 18 (11.4) 17 (11) 18 (11) per 10 years:
1.12 (1.00 to 1.25)
0.055
Average number of consultations per working day, n (%)
  < 15 197 (12) 31 (8) 121 (11) ref.
 15–25 567 (33) 123 (33) 356 (34) 0.78 (0.48 to 1.25) 0.30
 26–35 468 (27) 93 (25) 300 (28) 0.91 (0.56 to 1.50) 0.72
  > 35 474 (28) 123 (33) 281 (27) 0.71 (0.43 to 1.20) 0.21
Frequency of seeing/treating patients aged ≥ 70 years with polypharmacy, n (%)
 frequently / very frequently 1,469 (87) 310 (84) 942 (89) 1.63 (1.15 to 2.32) 0.006
 very rarely / rarely / occasionally 218 (13) 60 (16) 116 (11) ref.
Frequency of dealing with the topic of deprescribing medications in daily practice, n (%)
 frequently / very frequently 935 (56) 176 (48) 638 (60) 1.53 (1.18 to 1.97) 0.001
 very rarely / rarely / occasionally 729 (44) 194 (52) 420 (40) ref.
Frequency of deprescribing medications during consultations in daily practice, n (%)
 frequently / very frequently 438 (26) 76 (21) 305 (29) 1.46 (1.09 to 1.97) 0.012
 very rarely / rarely / occasionally 1,226 (74) 294 (79) 753 (71) ref. -
  1. adeprescribing defined as stopping or reducing the dosage of at least one medication; bmedian deprescribing behaviour corresponds to deprescribing or reducing the dosage of at least one medication in all of the 6 hypothetical patients; ccrude odds ratios from multilevel univariate logistic regression; dP-values from univariate logistic regression